Onderzoeker
Julia Katharina Schwarze
- Trefwoorden:Geneeskunde
- Disciplines:Andere basiswetenschappen niet elders geclassificeerd
Affiliaties
- Faculteit van de Geneeskunde en Farmacie (Faculteit)
Lid
Vanaf21 sep 2012 → Heden - Interne Geneeskunde en Endocrinologie (Departement)
Lid
Vanaf1 sep 2018 → Heden - Medische Oncologie (Departement)
Lid
Vanaf2 jul 2018 → 31 aug 2018 - Observerende Klinische wetenschappen (Departement)
Lid
Vanaf1 jun 2018 → Heden
Publicaties
1 - 10 of 13 results
- A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab(2021)
Auteurs: Gil Awada, Yanina Jansen, Julia Katharina Schwarze, Jens Tijtgat, Odrade Gondry, Sim Vermeulen, Sarah Warren, Kelly Schats, Pieter-Jan van Dam, Mark Kockx, et al.
Aantal pagina's: 18 - Intratumoral Combinatorial Administration of CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors(2020)
Auteurs: Julia Katharina Schwarze, Gil Awada, Louise Cras, Jens Tijtgat, Ramses Forsyth, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, Bart Neyns
Pagina's: 1-16Aantal pagina's: 16 - Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab(2020)
Auteurs: Anne Rogiers, Christophe Leys, Justine Lauwyck, Adrian Schembri, Gil Awada, Julia Katharina Schwarze, Jennifer De Cremer, Peter Theuns, Paul Maruff, Mark De Ridder, et al.
- Durable Complete Response of a Recurrent Mesencephalic Glioblastoma Treated with Trametinib and Low-Dose Dabrafenib in a Patient with Neurofibromatosis Type 1(2020)
Auteurs: Gil Awada, Daphne Serruys, Julia Katharina Schwarze, Lien Van De Voorde, Johnny Duerinck, Bart Neyns
Pagina's: 1031–1036Aantal pagina's: 6 - Axitinib plus avelumab in the treatment of recurrent glioblastoma(2020)
Auteurs: Gil Awada, Laila Ben Salama, Jennifer De Cremer, Julia Katharina Schwarze, Lydia Fischbuch, Laura Seynaeve, Stephanie Du Four, Anne-Marie Vanbinst, Alex Michotte, Hendrik Everaert, et al.
- An atypical sarcoid-like reaction during anti-protein death 1 treatment in a patient with metastatic melanoma(2020)
Auteurs: Stijn De Keukeleire, Julia Katharina Schwarze, Gil Awada, Hendrik Everaert, Anne-Marie Vanbinst, Louise Cras, Bart Neyns, S Aspeslagh
Pagina's: 524-527Aantal pagina's: 4 - Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy(2019)
Auteurs: Yanina Jansen, Simon Planken, Gil Awada, Julia Katharina Schwarze, Marleen Keyaerts, Hendrik Everaert, Bart Neyns
- Long-Term Survival, Quality of Life, and Psychosocial Outcomes in Advanced Melanoma Patients Treated with Immune Checkpoint Inhibitors(2019)
Auteurs: Anne Rogiers, Annelies Boekhout, Julia Katharina Schwarze, Gil Awada, Christian Blank, Bart Neyns
Aantal pagina's: 17 - Successful treatment with intralesional talimogene laherparepvec in two patients with immune checkpoint inhibitor-refractory, advanced-stage melanoma(2019)
Auteurs: Teofila Seremet, Simon Planken, Julia Katharina Schwarze, Yanina Jansen, Laura Vandeweerd, Robbe Van den Begin, Ioannis Tsechelidis, Danielle Lienard, Veronique Del Marmol, Bart Neyns
Pagina's: 85-88Aantal pagina's: 4 - ASCO 2018 Immunotherapy Highlights(2018)
Auteurs: Bart Neyns, Gil Awada, Julia Katharina Schwarze
Pagina's: 196-202